Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_assertion type Assertion NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_head.
- NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_assertion description "[The CCR-2 64I variant was associated with decreased risk of cervical cancer; homozygote carriers of the 64I variant had an odds ratio of 0.31 (0.12-0.77).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_provenance.
- NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_assertion evidence source_evidence_literature NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_provenance.
- NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_assertion SIO_000772 17688234 NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_provenance.
- NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_assertion wasDerivedFrom befree-20140225 NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_provenance.
- NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_assertion wasGeneratedBy ECO_0000203 NP883902.RApU-QwEursgpnvUnb8whZWvLMaFHuzDWwkCiqsFCsOwc130_provenance.